BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| EBITDA (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $3.0B | −27.5% | −10.6% | 4.8% |
| EBITDA (TTM) | $3.0B |
|---|---|
| YoY | −27.5% |
| 5-year CAGR | −10.6% |
| 10-year CAGR | 4.8% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2021 | $3.3B | −33.5% |
| 2020 | $5.0B | −33.3% |
| 2019 | $7.5B | +14.8% |
| 2018 | $6.5B | +1.7% |
| 2017 | $6.4B | +10.2% |
| 2016 | $5.8B | +6.2% |
| 2015 | $5.5B | +17.8% |
| 2014 | $4.7B | +52.9% |
| 2013 | $3.0B | +37.2% |
| 2012 | $2.2B | +6.6% |
| 2011 | $2.1B | +29.9% |
| 2010 | $1.6B | −6.9% |
| 2009 | $1.7B | +2.8% |
| 2008 | $1.7B | +44.4% |
| 2007 | $1.2B | — |